A CALL FOR NEW COMMUNICATION CHANNELS FOR EUROPEAN GYNAECOLOGICAL ONCOLOGY TRAINEES - A SURVEY AMONG MEMBERS OF THE EUROPEAN NETWORK OF YOUNG GYNAECOLOGICAL ONCOLOGISTS

2016 ◽  
Author(s):  
Kamil Zalewski
Keyword(s):  
Communication Channels ◽  
European Network ◽  
Gynaecological Oncology

Report from the European Society of Gynaecological Oncology (ESGO) 2020 State-of-the-Art Virtual Meeting

2021 ◽  
Vol 31 (5) ◽  
pp. 658-669
Author(s):  
Zoia Razumova ◽  
Nicolò Bizzarri ◽  
Joanna Kacperczyk-Bartnik ◽  
Andrei Pletnev ◽  
Antonio Gonzalez Martin ◽  
...  
Keyword(s):  
European Society ◽  
State Of The Art ◽  
Opinion Leaders ◽  
European Network ◽  
Case Presentation ◽  
Gynaecological Oncology ◽  
Virtual Meeting ◽  
Different Types ◽  
Cancer Guidelines ◽  
First Time

This is a report from the European Society of Gynaecological Oncology State-of-the-Art Virtual Meeting held December 14–16, 2020. The unique 3-day conference offered comprehensive state-of-the-art summaries on the major advances in the treatment of different types of gynecological cancers. Sessions opened with a case presentation followed by a keynote lecture and interactive debates with opinion leaders in the field. The speakers also presented scientific reviews on the clinical trial landscape in collaboration with the European Network of Gynecological Oncological Trial (ENGOT) groups. In addition, the new ESGO-ESRTO-ESP endometrial cancer guidelines were officially presented in public. This paper describes the key information and latest studies that were presented for the first time at the conference.

Subspecialty training in Europe: a report by the European Network of Young Gynaecological Oncologists

2020 ◽  
pp. ijgc-2020-002176
Author(s):  
Maximilian Lanner ◽  
Tanja Nikolova ◽  
Bojana Gutic ◽  
Natasha Nikolova ◽  
Andrei Pletnev ◽  
...  
Keyword(s):  
Online Education ◽  
Training System ◽  
Subspecialty Training ◽  
European Network ◽  
Exact Test ◽  
Electronic Survey ◽  
Gynaecological Oncology ◽  
Training Systems ◽  
Assessment Techniques ◽  
Perceived Relevance

BackgroundESGO (European Society of Gynaecological Oncology) and partners are continually improving the developmental opportunities for gynaecological oncology fellows. The objectives of this survey were to evaluate the progress in the infrastructure of the training systems in Europe over the past decade. We also evaluated training and assessment techniques, the perceived relevance of ENYGO (European Network of Young Gynaecological Oncologists) initiatives, and unmet needs of trainees.MethodologyNational representatives of ENYGO from 39 countries were contacted with an electronic survey. A graduation in well/moderately/loosely-structured training systems was performed. Descriptive statistical analysis and frequency tables, as well as two-sided Fisher’s exact test, were used.ResultsNational representatives from 33 countries answered our survey questionnaire, yielding a response rate of 85%. A national fellowship is offered in 22 countries (66.7%). A logbook to document progress during training is mandatory in 24 (72.7%) countries. A logbook of experience is only utilized in a minority of nations (18%) for assessment purposes. In 42.4% of countries, objective assessments are recognized. Trainees in most countries (22 (66.7%)) requested additional training in advanced laparoscopic surgery. 13 (39.4%) countries have a loosely-structured training system, 11 (33.3%) a moderately-structured training system, and 9 (27.3%) a well-structured training system.ConclusionSince the last publication in 2011, ENYGO was able to implement new activities, workshops, and online education to support training of gynaecological oncology fellows, which were all rated by the respondents as highly useful. This survey also reveals the limitations in establishing more accredited centers, centralized cancer care, and the lack of laparoscopic training.

Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey

2020 ◽  
Vol 30 (6) ◽  
pp. 819-824
Author(s):  
Stefano Greggi ◽  
Francesca Falcone ◽  
Cono Scaffa ◽  
Andreas du Bois ◽  
Eleftherios Pierre Pierre Samartzis ◽  
...  
Keyword(s):  
Fallopian Tube ◽  
Clinical Decision Making ◽  
Gynecologic Oncology ◽  
Disease Status ◽  
Diagnostic Tools ◽  
European Network ◽  
Peritoneal Carcinoma ◽  
Peritoneal Cancer ◽  
Gynaecological Oncology ◽  
Oncology Trial

ObjectiveLaparoscopy is one of the diagnostic tools available for the complex clinical decision-making process in advanced ovarian, fallopian tube, and peritoneal carcinoma. This article presents the results of a survey conducted within the European Network of Gynaecological Oncology Trial (ENGOT) group aimed at reviewing the current patterns of practice at gynecologic oncology centers with regard to the evaluation of resection in advanced ovarian, fallopian tube, and peritoneal carcinoma.MethodsA 24-item questionnaire was sent to the chair of the 20 cooperative groups that are currently part of the ENGOT group, and forwarded to the members within each group.ResultsA total of 142 questionnaires were returned. Only 39 respondents (27.5%) reported using some form of clinical (not operative) score for the evaluation of resection. The frequency of use of diagnostic laparoscopy to assess disease status and feasibility of resection was as follows: never, 21 centers (15%); only in select cases, 83 centers (58.5%); and routinely, 36 centers (25.4%). When laparoscopy was performed, 64% of users declared they made the decision to proceed with maximal effort cytoreductive surgery based on their personal/staff opinion, and 36% based on a laparoscopic score. To the question of whether laparoscopy should be considered the gold standard in the evaluation of resection, 71 respondents (50%) answered no, 66 respondents (46.5%) answered yes, whereas 5 respondents (3.5%) did not provide an answer.ConclusionsThis study found that laparoscopy was routinely performed to assess feasibility of cytoreduction in only 25.4% of centers in Europe. However, it was commonly used to select patients and in a minority of centers it was never used . When laparoscopy was adopted, the treatment strategy was based on laparoscopic scores only in a minority of centers.

Assessment of palliative care training in gynaecological oncology: a survey among European Network of Young Gynae-Oncologists (ENYGO) members

2020 ◽  
pp. bmjspcare-2020-002233
Author(s):  
Mariaclelia La Russa ◽  
Ignacio Zapardiel ◽  
Kamil Zalewski ◽  
Rene Laky ◽  
Polat Dursun ◽  
...  
Keyword(s):  
Palliative Care ◽  
Healthcare Providers ◽  
European Network ◽  
University Hospitals ◽  
Gynaecological Oncology ◽  
Systematic Training ◽  
Oncology Practice ◽  
Training Programmes ◽  
Eol Care

IntroductionPalliative care is an important aspect of gynaecological oncology practice. In order to successfully integrate end-of-life (EOL) care in the disease trajectory, it is crucial to incorporate systematic training in subspecialty programmes in gynaecological oncology. We aimed to evaluate the quality of training in palliative care across gynaecological oncology fellows in Europe and to provide a framework to facilitate learning opportunities.MethodsA web-based questionnaire was sent to members of the European Network of Young Gynae-Oncologists (ENYGO). The survey consisted of 36 items covering six domains: respondents’ characteristics, quality and quantity of teaching, curriculum achievements, observation and feedback, EOL clinical practice and attitudes about palliative care.ResultsOf the 703 clinicians enrolled in the study, 142 responded (20.2%). Although the majority worked in university hospitals, only half of them (47%) were in a formal subspecialty programme. The majority of respondents (60%) were trained without a mandatory rotation in palliative care units and considered the quality of EOL care teaching as ‘very poor’ or ‘poor’ (57.7%). The majority of respondents (71.6%) did not receive any supervision or feedback at the time of their first consultation on changing the goals of care.ConclusionOur study underlines lack of structured teaching and supervision in palliative care contents among European fellows in gynaecological oncology. Broad education of healthcare providers is a key factor to achieve the integration of palliative care in gynaecological oncology practice. Stakeholders like European Society of Gynaecological Oncology/ENYGO play an important role to facilitate educational activities and training programmes targeting to EOL care.

The European Society of Gynaecological Oncology: Update on Objectives and Educational and Research Activities

2012 ◽  
pp. 335-338
Author(s):  
Renata Brantnerova ◽  
Ranjit Manchanda ◽  
Nicoletta Colombo
Keyword(s):  
European Society ◽  
Research Collaboration ◽  
Planning Process ◽  
Gynecologic Oncology ◽  
European Network ◽  
Gynecologic Cancers ◽  
Gynaecological Oncology ◽  
Research Activities ◽  
Oncology Trial ◽  
Poster Presentations

Overview: The European Society of Gynaecological Oncology (ESGO) is the principal European society contributing to the study, prevention, and treatment of gynecologic cancers. Founded in 1983, ESGO has more than 1,300 members in more than 40 European countries and worldwide who benefit from ESGO's innovative education and research initiatives and networking opportunities. ESGO objectives have been recently identified through a strategic planning process and include education, care, research, collaboration, awareness, and sustainability. As a leading gynecologic oncology society, ESGO holds biennial meetings where experts meet to discuss latest advances in gynecologic treatment and care. The 17th International Meeting of ESGO (ESGO 17) proved to be a resounding success, with 2,700 delegates and speakers who gathered from around the world in the cultured city of Milan, Italy. The structure of the congress included keynote lectures, debates, state-of-the art sessions, and focused sunrise sessions, together with oral and poster presentations and satellite symposia sponsored by pharmaceutical companies. For the first time, during ESGO 17 the Society organized a seminar for European patient groups with an interest in gynecologic cancers with the aim of facilitating different patientrelated activities across Europe. Moreover, The European Network of Young Gynaecologic Oncologists (ENYGO), the European Network of Gynaecologic Oncology Trial Groups (ENGOT), and the European Network of Translational Research in Gynaecological Oncology (ENTRIGO) had their own section during ESGO 17. ESGO also holds numerous workshops throughout the calendar year and provides clinical and research grants, online educational materials, webcasts, and numerous networking opportunities

scholarly journals The need for accredited training in gynaecological oncology: a report from the European Network of Young Gynaecological Oncologists (ENYGO)

2013 ◽  
Vol 24 (4) ◽  
pp. 944-952 ◽  
Author(s):  
R. Manchanda ◽  
M. Godfrey ◽  
L.A. Wong-Taylor ◽  
M.J. Halaska ◽  
M. Burnell ◽  
...  
Keyword(s):  
European Network ◽  
Gynaecological Oncology

Abstract #1103: Comprehensive Diabetes Care Through Continuous Communication Channels to Patients with Diabetes

2017 ◽  
Vol 23 ◽  
pp. 290
Author(s):  
Vamsi Kolukula ◽  
Jayashree Gopal ◽  
Shantharam Duvuru ◽  
Kalpana Dash ◽  
Sanjiv Shah ◽  
...  
Keyword(s):  
Diabetes Care ◽  
Communication Channels ◽  
Patients With Diabetes

Jahrestagung der European Society of Gynaecological Oncology (ESGO): Neue Erkenntnisse zum Ovarial- und Endometriumkarzinom

2011 ◽  
Vol 02 (06) ◽  
pp. 272-272
Author(s):  
Bettina Reich
Keyword(s):  
European Society ◽  
Gynaecological Oncology

Beim alle 2 Jahre stattfindenden ESGO-Kongress in Mailand wurde deutlich, dass insbesondere beim Ovarialkarzinom zwar keine Sprunginnovationen zu erwarten sind, aber es stetig – Schritt für Schritt – voran geht. Obwohl das Abschneiden der zielgerichteten Therapie mit Abagovomab enttäuschend ist, zeigen weitere Ergebnisse, dass dieser Therapieansatz durchaus seinen Stellenwert in dieser Indikation besitzt. Entscheidend scheint beim Rückfall das platinfreie Intervall zu sein. Beim Endometriumkarzinom deutet sich an, dass Everolimus eine Bereicherung des therapeutischen Regimes sein könnte.

Sign in / Sign up

Export Citation Format

Share Document